.

• New 72-page Executive Informational Overview® (EIO) by Crystal Research Associates on Tauriga Sciences, Inc. (TAUG-OTC) is available at www.crystalra.com

• Tauriga Sciences is a life sciences company focused on acquiring and developing a portfolio of technologies which could provide a clear and fast path to commercialization

o Pilus Energy LLC for the development of a wastewater-to-value clean energy solution based on Bacterial Robotics’ microbial technology

o Honeywood LLC for the development and commercialization of topical medicinal cannabis products

o Green Innovations Ltd. for the commercialization of bamboo-based, hospital-grade paper products

o Bacterial Robotics LLC for development of a synthetic biology-based wastewater remediation platform for the nuclear industry

Crystal Research Associates Presents:

New Independent Equity Research

.

• Crystal clear, comprehensive report on a company in a manner that is easily understood by the Wall Street financial community

• Product/technology/service offerings, market size(s), key intellectual property, leadership, growth strategy, competition, risks, financial statements, key events, and other fundamental information are detailed

• Free of investment ratings, target prices, and forward-looking financial models

• Complete risks and disclosures

• Written exclusively by experienced, award-winning analysts

What is an EIO?

.

Overview of Tauriga Sciences, Inc. (TAUG-OTC)

• Tauriga’s business model includes the acquisition of licenses, equity stakes, rights on both an exclusive and non-exclusive basis, and entire businesses.

• The Company’s selection criteria for potential products, technologies, or businesses entails that they meet the following:

1) a focus on innovation

2) a near-term revenue opportunity

3) a clear path to commercialization

4) large addressable markets

• Tauriga is focused on opportunities believed to have near-term revenue potential that do not require the risky, lengthy, and costly clinical regulatory approval process normally associated with drug development in the U.S.

.

Tauriga Sciences’ Summary of Assets

Pilus Energy Honeywood LLC

Green Innovations LTD Bacterial Robotics

Licensing

Acquisitions

.

• Wastewater-to-energy platform using genetically enhanced bacteria, called BactoBots™, to clean pollutants from wastewater while generating electricity and valuable biogases

• BactoBots™ are used in conjunction with a scalable electrogenic bioreactor (EBR)—a microbial fuel cell that harnesses abilities of bacteria while aiding in collection of economically important byproducts

• Following initial proof of concept, Pilus Energy has announced a pilot study of its wastewater-to-value technology on a commercial scale through a $1.7 million project with the Metropolitan Sewer District of Greater Cincinnati (MSDGC), and is also pursuing a pilot with large brewery and beverage manufacturer

• Tauriga eventually seeks to outlicense BactoBots™ manufacture to distributors and customers worldwide

• The genetics rights management (GeRM™) platform needed to activate the BactoBots™ functions as anti-theft system as Tauriga retains control of GeRM™ creation and supply

• The global water industry is currently estimated to have a market value of $500 billion, and is projected to reach $1 trillion by 2020

Pilus Energy Subsidiary

.

• Topical medicinal cannabis, which includes Doc Green’s Therapeutic Healing Cream, shown below, (sold at >100 dispensaries in California), and “Vapura” Vapor Cartridge

• Able to manufacture medicinal cannabis products and high-grade medically sterile cannabis extracts, and involved in licensing brands/delivery technologies as well as supplying laboratory services infrastructure for fast-growing medical cannabis industry

• Medical marijuana industry is a new frontier in healthcare, as more patients seek out natural remedies and safer alternatives to side effect-heavy prescription medicines

• Many medical users desire therapeutic effect of cannabis without the “high,” creating a market for Honeywood’s topical, non-psychoactive (non-high-producing) products

The “Cannabis Complements” Product Line

• Tauriga’s natural wellness business also includes Cannabis Complements, a line of non-cannabis dietary supplements and natural wellness products

• Tauriga’s first cannabis-free, natural supplement for appetite control, called Satietiva, was recently launched in Colorado

Honeywood Subsidiary and “Cannabis Complements”

.

• On May 31, 2013, Tauriga executed a license agreement with Green Hygienics, Inc. (GHI), a subsidiary of Green Innovations

• GHI is the North American distributor of American Hygienics Corporation’s 100% tree-free, bamboo-based product line, which includes personal care and paper-based goods

• GHI license agreement provides Tauriga with a five-year right to market and sell an exclusive line of GHI’s products, including 100% tree-free, bamboo-based, biodegradable, hospital-grade wipes as well as other similar products, in North America

• Company plans to sell the products to commercial entities, including medical facilities and schools

Green Innovations Ltd.’s License

.

• Bacterial Robotics specializes in using synthetic biology to create unique bacterial “robots,” called BactoBots™

• Microscopic bacteria-based organisms are engineered to conduct specific tasks as needed for the water, energy, chemical, and pharmaceutical industries

• Tauriga’s strategic alliance with Bacterial Robotics refers to the class of BactoBots™ known as the NuclearBot™ technology—a synthetic biology method for creating bacteria designed to cleanse the wastewater generated through nuclear power plant operations

• JV is to market and sell products and services based on the NuclearBot™ technology as well as to sublicense the NuclearBot™ intellectual property

Bacterial Robotics LLC’s License

.

• Entered into a strategic alliance agreement with Bacterial Robotics LLC for the creation of a joint venture to develop and commercialize the NuclearBot™ technology

• Acquired Bacterial Robotics’ subsidiary Pilus Energy LLC, a developer of alternative wastewater-to-value clean-tech energy solutions

• Initiated a $1.7 million pilot test of its Pilus Energy platform with the Metropolitan Sewer District of Greater Cincinnati (MSDGC), and received EPA approval of the test

• Acquired California-based medicinal cannabis firm Honeywood LLC, a developer of a line of non-narcotic topical medicinal cannabis products, and commenced development of Cannabis Complements products

o Introduced its first product from the Cannabis Complements product line, Satietiva (a natural supplement for appetite control), into the Colorado market

• Strengthened balance sheet by reducing in excess of $400,000 in convertible debt, and performed multiple financing activities to fund acquisitions and operations

• Entered into an investment banking agreement with Dragoon Capital, Inc.

Recently Achieved Milestones

.

• Begin Pilus Energy’s second pilot test

• Expand the Cannabis Complements product line

• Retire all remaining convertible debt

• Ramp-up revenues through the operations of its natural wellness businesses (Honeywood and Tauriga’s Cannabis Complements product line) in order to up-list its common shares to national stock exchange (e.g., NASDAQ or NYSE)

Potential Upcoming Milestones

.

• Stella M. Sung, Ph.D., Chairman and CEO—Almost 20 years experience as life science VC and biotechnology executive; general partner/managing director of 3 life science venture funds; led 7 venture rounds, co-founded 2 biotech companies; served on 7 boards of directors and served as chairman of the board for 4 biotech companies; successful VC track record: chief business officer, Cylene Pharmaceuticals, business development officer, Avita Medical (ASX: AVH and OTCQX: AVMXY); Harvard PhD in Chemistry under Professor Dudley Herschbach (1986 Nobel Laureate)

• Seth M. Shaw, VP, Strategic Planning—Expertise in building companies and capital raising; raised > $60 M in aggregate for several companies; founder, Novastar Resources (now Lightbridge [NASDAQ: LTBR]), key relationships in the nuclear power industry; founding CFO, Physician Therapeutics; Cornell University degree

Management

.

• Lawrence May, M.D., Chief Medical Officer—Board certified internist with broad experience in clinical medicine, academics, media and business; previously on the faculty of the UCLA medical school; previously Executive Vice President for Medical and Scientific Affairs for Herbalife; undergraduate degree magna cum laude in economics from Harvard University (’70), MD from Harvard Medical School (’74) and residency in internal medicine at Massachusetts General Hospital.

Management (cont.)

.

To read the entire 72-page EIO on Tauriga Sciences, Inc. (TAUG-OTC)

or find information on other companies under coverage, please visit www.crystalra.com.

.

Crystal Research Associates, LLC (www.crystalra.com) is an independent research firm that has provided institutional-quality research on small- and mid-cap companies for the past decade. We are led by veteran Wall Street sell-side analyst Jeffrey Kraws, who is well known by the international financial media for his years of work on Wall Street and for providing consistent award-winning analyses and developing long-term relationships on both the buy-side and sell-side. He has been consistently ranked among the Top Ten Analysts for pharmaceutical stock performance in the world for almost two decades as well as ranked as the Number One Stock Picker in the world for pharmaceuticals by Starmine and for estimates from Zacks. Additionally, Mr. Kraws has been 5-Star ranked for top biotechnology stock performance by Starmine.

About Us

Corporate Headquarters:880 Third Avenue, 6th FloorNew York, NY 10022Office: (212) 851-6685Fax: (609) 395-9339

Satellite Office Location:2500 Quantum Lakes Drive, Suite 203Boynton Beach, FL 33426Office: (561) 542-6903Fax: (561) 853-2246

Jeffrey J. Kraws,Chief Executive Officer

Karen B. GoldfarbPresident & COO

.

FACEBOOK — https://www.facebook.com/CrystalResearchAssociates

TWITTER — http://twitter.com/crystalresearch

YOUTUBE — https://www.youtube.com/user/crystalrsch

LINKEDIN — http://www.linkedin.com/company/crystal-research-associates

SLIDESHARE — http://www.slideshare.net/crystalresearchassociates

Connect with Crystal Research Associates